Health and Medical Guide to the Blood and Lymphatic System       Blood/Lymphatic System Health information topics about Blood/Lymphatic System: ABO Blood Groups (Blood and Blood Disorders) Anatomy (Anatomy) Anemia (Anemia) Aplastic Anemia (Anemia) Behcet's Syndrome (Behcet's Syndrome) Bleeding Disorders (Bleeding Disorders) Blood and Blood Disorders (Blood and Blood Disorders) Blood Cells (Blood and Blood Disorders) Blood Clots (Bleeding Disorders, Thrombophlebitis) Blood Coagulation Disorders (Bleeding Disorders, Hemophilia) Blood Donation (Blood Transfusion and Donation) Blood Transfusion and Donation (Blood Transfusion and Donation) Bone Marrow Diseases (Bone Marrow Diseases) Bone Marrow Transplantation (Bone Marrow Transplantation) Childhood Leukemia (Leukemia, Childhood) Cholesterol (Cholesterol) Edema (Edema) Fistulas (Fistulas) Folate (Anemia, Folic Acid) Hairy Cell Leukemia (Leukemia, Adult Chronic) HDL (Cholesterol) Hemochromatosis (Hemochromatosis) Hemophilia (Hemophilia) Hodgkin's Disease (Hodgkin's Disease) Iron Deficiency Anemia (Anemia) LDL (Cholesterol) Leukemia, Adult Acute (Leukemia, Adult Acute) Leukemia, Adult Chronic (Leukemia, Adult Chronic) Leukemia, Childhood (Leukemia, Childhood) Lymphatic Diseases (Lymphatic Diseases) Lymphedema (Lymphatic Diseases) Lymph Nodes (Lymphatic Diseases) Lymphoma (Lymphoma) Multiple Myeloma (Multiple Myeloma) Myelodysplastic Syndromes (Bone Marrow Diseases) Myeloproliferative Disorders (Bone Marrow Diseases) Non-Hodgkin's Lymphoma (Lymphoma) Plasmacytoma (Multiple Myeloma) Sarcoidosis (Sarcoidosis) Sickle Cell Anemia (Sickle Cell Anemia) Spleen Diseases (Spleen Diseases) Splenomegaly (Spleen Diseases) Swollen Glands (Lymphatic Diseases) Thalassemia (Anemia) Thrombocytopenia (Bleeding Disorders) von Willebrand Disease (Bleeding Disorders   Lymphology/Lymphedema News From Medical News Today Latest Health News and Medical News posted throughout the day, every day. BioMarin Receives Orphan Drug Designation From The FDA For BMN-701 For The Tr... 1 Sep 2010 at 4:00am BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease... Shire Announces European Approval Of VPRIV(R) (velaglucerase Alfa) For The Tr... 27 Aug 2010 at 5:00am Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease... Two-Year Data From Phase 2 Trial Of Genzyme's Eliglustat Tartrate For Gaucher... 24 Aug 2010 at 4:00am Genzyme Corporation (NASDAQ: GENZ) announced that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers... Breast Cancer Survivors Don't Need To Be Afraid Of Air Travel: U Of A Study 21 Aug 2010 at 2:00am University of Alberta researcher Margie McNeely says results from an international study she was part of indicates certain precautions about the risk of lymphedema for breast cancer survivors are outdated... HemaQuest Pharmaceuticals Initiates Phase 2 Clinical Trial In EBV-Related Mal... 12 Aug 2010 at 4:00am HemaQuest Pharmaceuticals announced that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival... Ease The Aftermath Of Breast Cancer With New Imaging Technique 5 Aug 2010 at 3:00am A new study of breast cancer survivors may help physicians ease a common side effect of cancer treatments. The collaborative research by Eva Sevick, Ph.D., Director of the Center for Molecular Imaging at the University of Texas Health Science Center in Houston (UTHSC), and Caroline Fife, M.D., Director of the Memorial Herman Wound Care Clinic at UTHSC, could bring relief to millions... Protalix BioTherapeutics Receives PDUFA Date For Taliglucerase Alfa 14 Jul 2010 at 4:00am Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced that the Company's New Drug Application (NDA) for taliglucerase alfa has been accepted for review by the U.S. Food and Drug Administration (FDA). The FDA granted taliglucerase alfa a standard review time of ten months, assigning a Prescription Drug User Fee Act (PDUFA) action date of February 25, 2011... Decongestive Physiotherapy Helps Patients With Painful Leg Swelling 25 Jun 2010 at 4:00am For patients with painful swelling of the legs caused by chronic venous insufficiency (CVI), a combination treatment approach called "complete decongestive physiotherapy" improves symptoms, walking ability, and quality of life, reports a study in Topics in Geriatric Rehabilitation... Inconclusive Results From Research Into Biologics-Associated Cancer Risk 18 Jun 2010 at 4:00am Biologics-naive Juvenile Idiopathic Arthritis (JIA) patients may have an increased risk of cancer compared with the general Swedish population, according to research presented at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy... Future Continues To Brighten For Children With Velocardiofacial Syndrome 4 Jun 2010 at 3:00am Research about quality of life is improving the treatment of children with velocardiofacial syndrome, a chronic, genetic condition with a wide range of symptoms, including congenital heart disease, palatal abnormalities (e.g. cleft palate), and learning difficulties... Shire Announces FDA Approval Of VPRIV(TM) (velaglucerase Alfa For Injection) ... 29 May 2010 at 3:00am Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients... Discovery Of Gene Mutation Linked To Lymphatic Dysfunction Could Lead To Firs... 29 May 2010 at 2:00am A genetic mutation for inherited lymphedema associated with lymphatic function has been discovered that could help create new treatments for the condition, say researchers at the University of Pittsburgh Graduate School of Public Health. Their findings are reported in the June issue of the American Journal of Human Genetics... A Century-Old Puzzle Comes Together, Scientists ID Potential Protein Trigger ... 4 May 2010 at 6:00am Lung researchers at Johns Hopkins have identified a possible protein trigger responsible for sarcoidosis, a potentially fatal inflammatory disease marked by tiny clumps of inflammatory cells that each year leave deep, grainy scars on the lungs, lymph nodes, skin and almost all major organs in hundreds of thousands of Americans... Study Offers First Clinical Evidence Of Anti-Cancer Drug Triggering Viral Inf... 13 Apr 2010 at 3:00am Important advances in the fight against cancer have come as researchers proved that viruses and cancers interact in ways that were previously unknown to scientists. A new study led by UNC scientists shows that a common cancer drug can activate a viral infection that, paradoxically, can help anti-viral medications eradicate virus-associated cancer... More News From The Journal Of Clinical Investigation: April 1, 2010 3 Apr 2010 at 2:00am METABOLIC DISEASE: Differential drug response in lean and obese patients explained One thing that predisposes individuals who are obese to type 2 diabetes is the persistent, low-level inflammation that results, in part, from dysregulation of the function of white fat tissue in the abdominal cavity between the internal organs (visceral white fat tissue)...     HealthBusinessBuilder.com Build your Health Business Fast!